To include your compound in the COVID-19 Resource Center, submit it here.

Rising Cologuard sales boost Exact Sciences' shares

Exact Sciences Corp. (NASDAQ:EXAS) climbed $4.89 (10%) to $54.99 on Tuesday after its 3Q17 earnings showed sales

Read the full 178 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE